SIGA Technologies
SIGA
#7361
Rank
โ‚น39.88 B
Marketcap
โ‚น556.99
Share price
-2.21%
Change (1 day)
8.89%
Change (1 year)

SIGA Technologies (SIGA) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น15.44 Billion

According to SIGA Technologies's latest financial reports the company has โ‚น15.44 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

SIGA Technologies - Cash on Hand chart (from 1997 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น13.33 B6.65%
2023-12-31โ‚น12.49 B52.9%
2022-12-31โ‚น8.17 B6.49%
2021-12-31โ‚น7.67 B-10.96%
2020-12-31โ‚น8.62 B85.3%
2019-12-31โ‚น4.65 B-33.89%
2018-12-31โ‚น7.03 B455.07%
2017-12-31โ‚น1.26 B-34.99%
2016-12-31โ‚น1.95 B-73.96%
2015-12-31โ‚น7.49 B18.52%
2014-12-31โ‚น6.31 B12.03%
2013-12-31โ‚น5.64 B221.79%
2012-12-31โ‚น1.75 B-32.72%
2011-12-31โ‚น2.60 B172.6%
2010-12-31โ‚น0.95 B5.67%
2009-12-31โ‚น0.90 B710.69%
2008-12-31โ‚น0.11 B-58.38%
2007-12-31โ‚น0.26 B-43.1%
2006-12-31โ‚น0.47 B490.79%
2005-12-31โ‚น79.76 M-8.87%
2004-12-31โ‚น87.52 M33.43%
2003-12-31โ‚น65.59 M-33.89%
2002-12-31โ‚น99.21 M-34.68%
2001-12-31โ‚น0.15 B90.63%
2000-12-31โ‚น79.68 M4.24%
1999-12-31โ‚น76.44 M-64.04%
1998-12-31โ‚น0.21 B-49.44%
1997-12-31โ‚น0.42 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Emergent BioSolutions
EBS
โ‚น22.05 B 42.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น52.39 B 239.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น68.53 B 343.66%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚น0.14 B-99.09%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น19.12 B 23.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น76.45 B 394.89%๐Ÿ‡บ๐Ÿ‡ธ USA